We collected information about Biogen Idec Stock After Hours for you. Follow the liks to find out everything about Biogen Idec Stock After Hours.
https://www.nasdaq.com/market-activity/stocks/biib/after-hours
Biogen Inc. Common Stock (BIIB) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
https://www.marketwatch.com/investing/stock/BIIB
Biogen stock price target cut to $502 from $647 at Truist. Oct. 21, 2021 at 7:30 a.m. ET by Tomi Kilgore.
https://www.marketwatch.com/investing/stock/IDP?countrycode=XE
IDP | Complete Biogen Idec Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
https://www.nasdaq.com/market-activity/stocks/biib
About Biogen Inc. 225 BINNEY STREET, CAMBRIDGE, Massachusetts, 2142, United States +1 617 679-2000. Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug ...
https://finance.yahoo.com/quote/BIIB/
Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing. ... in 5 hours 39 minutes. S&P 500 ... Art Scene Is ...
https://www.cnbc.com/quotes/BIIB
Biogen Inc. BIIB. : NASDAQ. WATCHLIST +. RT Quote | Last NASDAQ LS, VOL From CTA | USD. After Hours: Last | 11/15/21 EST. 272.00 +0.18 (+0.07%)
https://www.google.com/finance/quote/BIIB:NASDAQ
Biogen Stock Slips as Head of Research Retires Amid Aduhelm Rollout Stumbles. MarketWatch. 1 week ago. Biogen shares slide 4% after EU advisory committee says it …
https://www.msn.com/en-us/money/stockdetails/fi-a1ohur
View the latest BIIB stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of BIOGEN INC.. msn back to msn home money. ... After Hours : 275.40-3.28-1.18%.
https://www.benzinga.com/general/biotech/21/12/24378827/sage-therapeutics-biogen-share-one-year-zuranolone-50mg-data-in-depression-patients
2 days ago · Sage Therapeutics Inc (NASDAQ: SAGE) and Biogen Inc (NASDAQ: BIIB) have announced 12-month data for the cohort of patients (n=199) who received zuranolone 50 mg once for 14-days as their initial ...
https://www.benzinga.com/general/biotech/21/11/24149651/european-regulator-votes-down-biogens-alzheimers-drug
Recently, Biogen announced new Phase 3 findings that provide further evidence of aducanumab's effect on lowering amyloid-beta plaque and downstream tau pathology. Price Action: BIIB shares are ...
Searching for Biogen Idec Stock After Hours?
You can just click the links above. The info is collected for you.
